Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities (CARES)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Takeda
Teijin America, Inc.
Information provided by (Responsible Party):
Takeda Identifier:
First received: April 7, 2010
Last updated: August 11, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):